Cargando…

Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition

Aldosterone (Aldo), when overproduced, is a cardiotoxic hormone underlying heart failure and hypertension. Aldo exerts damaging effects via the mineralocorticoid receptor (MR) but also activates the antiapoptotic G protein-coupled estrogen receptor (GPER) in the heart. G protein-coupled receptor (GP...

Descripción completa

Detalles Bibliográficos
Autores principales: Maning, Jennifer, McCrink, Katie A., Pollard, Celina M., Desimine, Victoria L., Ghandour, Jennifer, Perez, Arianna, Cora, Natalie, Ferraino, Krysten E., Parker, Barbara M., Brill, Ava R., Aukszi, Beatrix, Lymperopoulos, Anastasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215681/
https://www.ncbi.nlm.nih.gov/pubmed/32326036
http://dx.doi.org/10.3390/ijms21082868
_version_ 1783532243384270848
author Maning, Jennifer
McCrink, Katie A.
Pollard, Celina M.
Desimine, Victoria L.
Ghandour, Jennifer
Perez, Arianna
Cora, Natalie
Ferraino, Krysten E.
Parker, Barbara M.
Brill, Ava R.
Aukszi, Beatrix
Lymperopoulos, Anastasios
author_facet Maning, Jennifer
McCrink, Katie A.
Pollard, Celina M.
Desimine, Victoria L.
Ghandour, Jennifer
Perez, Arianna
Cora, Natalie
Ferraino, Krysten E.
Parker, Barbara M.
Brill, Ava R.
Aukszi, Beatrix
Lymperopoulos, Anastasios
author_sort Maning, Jennifer
collection PubMed
description Aldosterone (Aldo), when overproduced, is a cardiotoxic hormone underlying heart failure and hypertension. Aldo exerts damaging effects via the mineralocorticoid receptor (MR) but also activates the antiapoptotic G protein-coupled estrogen receptor (GPER) in the heart. G protein-coupled receptor (GPCR)-kinase (GRK)-2 and -5 are the most abundant cardiac GRKs and phosphorylate GPCRs as well as non-GPCR substrates. Herein, we investigated whether they phosphorylate and regulate cardiac MR and GPER. To this end, we used the cardiomyocyte cell line H9c2 and adult rat ventricular myocytes (ARVMs), in which we manipulated GRK5 protein levels via clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 and GRK2 activity via pharmacological inhibition. We report that GRK5 phosphorylates and inhibits the cardiac MR whereas GRK2 phosphorylates and desensitizes GPER. In H9c2 cardiomyocytes, GRK5 interacts with and phosphorylates the MR upon β(2)-adrenergic receptor (AR) activation. In contrast, GRK2 opposes agonist-activated GPER signaling. Importantly, GRK5-dependent MR phosphorylation of the MR inhibits transcriptional activity, since aldosterone-induced gene transcription is markedly suppressed in GRK5-overexpressing cardiomyocytes. Conversely, GRK5 gene deletion augments cardiac MR transcriptional activity. β(2)AR-stimulated GRK5 phosphorylates and inhibits the MR also in ARVMs. Additionally, GRK5 is necessary for the protective effects of the MR antagonist drug eplerenone against Aldo-induced apoptosis and oxidative stress in ARVMs. In conclusion, GRK5 blocks the cardiotoxic MR-dependent effects of Aldo in the heart, whereas GRK2 may hinder beneficial effects of Aldo through GPER. Thus, cardiac GRK5 stimulation (e.g., via β(2)AR activation) might be of therapeutic value for heart disease treatment via boosting the efficacy of MR antagonists against Aldo-mediated cardiac injury.
format Online
Article
Text
id pubmed-7215681
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72156812020-05-22 Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition Maning, Jennifer McCrink, Katie A. Pollard, Celina M. Desimine, Victoria L. Ghandour, Jennifer Perez, Arianna Cora, Natalie Ferraino, Krysten E. Parker, Barbara M. Brill, Ava R. Aukszi, Beatrix Lymperopoulos, Anastasios Int J Mol Sci Article Aldosterone (Aldo), when overproduced, is a cardiotoxic hormone underlying heart failure and hypertension. Aldo exerts damaging effects via the mineralocorticoid receptor (MR) but also activates the antiapoptotic G protein-coupled estrogen receptor (GPER) in the heart. G protein-coupled receptor (GPCR)-kinase (GRK)-2 and -5 are the most abundant cardiac GRKs and phosphorylate GPCRs as well as non-GPCR substrates. Herein, we investigated whether they phosphorylate and regulate cardiac MR and GPER. To this end, we used the cardiomyocyte cell line H9c2 and adult rat ventricular myocytes (ARVMs), in which we manipulated GRK5 protein levels via clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 and GRK2 activity via pharmacological inhibition. We report that GRK5 phosphorylates and inhibits the cardiac MR whereas GRK2 phosphorylates and desensitizes GPER. In H9c2 cardiomyocytes, GRK5 interacts with and phosphorylates the MR upon β(2)-adrenergic receptor (AR) activation. In contrast, GRK2 opposes agonist-activated GPER signaling. Importantly, GRK5-dependent MR phosphorylation of the MR inhibits transcriptional activity, since aldosterone-induced gene transcription is markedly suppressed in GRK5-overexpressing cardiomyocytes. Conversely, GRK5 gene deletion augments cardiac MR transcriptional activity. β(2)AR-stimulated GRK5 phosphorylates and inhibits the MR also in ARVMs. Additionally, GRK5 is necessary for the protective effects of the MR antagonist drug eplerenone against Aldo-induced apoptosis and oxidative stress in ARVMs. In conclusion, GRK5 blocks the cardiotoxic MR-dependent effects of Aldo in the heart, whereas GRK2 may hinder beneficial effects of Aldo through GPER. Thus, cardiac GRK5 stimulation (e.g., via β(2)AR activation) might be of therapeutic value for heart disease treatment via boosting the efficacy of MR antagonists against Aldo-mediated cardiac injury. MDPI 2020-04-20 /pmc/articles/PMC7215681/ /pubmed/32326036 http://dx.doi.org/10.3390/ijms21082868 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Maning, Jennifer
McCrink, Katie A.
Pollard, Celina M.
Desimine, Victoria L.
Ghandour, Jennifer
Perez, Arianna
Cora, Natalie
Ferraino, Krysten E.
Parker, Barbara M.
Brill, Ava R.
Aukszi, Beatrix
Lymperopoulos, Anastasios
Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
title Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
title_full Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
title_fullStr Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
title_full_unstemmed Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
title_short Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
title_sort antagonistic roles of grk2 and grk5 in cardiac aldosterone signaling reveal grk5-mediated cardioprotection via mineralocorticoid receptor inhibition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215681/
https://www.ncbi.nlm.nih.gov/pubmed/32326036
http://dx.doi.org/10.3390/ijms21082868
work_keys_str_mv AT maningjennifer antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT mccrinkkatiea antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT pollardcelinam antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT desiminevictorial antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT ghandourjennifer antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT perezarianna antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT coranatalie antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT ferrainokrystene antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT parkerbarbaram antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT brillavar antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT aukszibeatrix antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition
AT lymperopoulosanastasios antagonisticrolesofgrk2andgrk5incardiacaldosteronesignalingrevealgrk5mediatedcardioprotectionviamineralocorticoidreceptorinhibition